2022

1. New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming

   Journal of Experimental and Clinical Cancer Research, Vol. 41, Núm. 1